US Stock MarketDetailed Quotes

Tenaya Therapeutics (TNYA)

Watchlist
  • 0.6722
  • -0.0117-1.71%
Close Apr 24 15:59 ET
  • 0.6900
  • +0.0178+2.65%
Post 20:01 ET
145.87MMarket Cap-1.14P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Tenaya Therapeutics (TNYA) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
24.57%-68.26M
24.19%-13.94M
21.36%-15.6M
33.89%-15.61M
19.36%-23.11M
11.34%-90.5M
16.13%-18.39M
16.08%-19.84M
9.93%-23.62M
5.38%-28.66M
Net income from continuing operations
18.48%-90.6M
15.36%-20.18M
20.91%-20.28M
20.89%-23.28M
16.64%-26.86M
10.44%-111.13M
20.37%-23.84M
12.04%-25.63M
11.54%-29.43M
-1.55%-32.23M
Depreciation and amortization
-0.38%8.44M
-12.54%1.83M
-11.28%1.86M
-1.84%2.08M
23.48%2.66M
-2.52%8.47M
-4.22%2.09M
-3.67%2.1M
-3.28%2.12M
1.17%2.16M
Other non cash items
-23.26%2.9M
-12.10%770K
-38.52%688K
-23.15%674K
-15.30%764K
12.69%3.77M
1.15%876K
31.96%1.12M
5.79%877K
11.91%902K
Change In working capital
69.03%-2.46M
186.20%893K
30.07%-921K
151.93%1.01M
5.61%-3.44M
-40.42%-7.93M
-54.40%-1.04M
-7.60%-1.32M
-383.89%-1.94M
17.97%-3.64M
-Change in prepaid assets
-36.17%547K
1.18%-167K
-591.07%-774K
181.91%1.95M
-202.91%-460K
748.51%857K
91.16%-169K
-108.75%-112K
88.28%691K
22.13%447K
-Change in payables and accrued expense
83.14%-898K
23,571.43%1.66M
212.41%471K
59.48%-744K
25.86%-2.28M
-419.10%-5.33M
-99.69%7K
72.29%-419K
-182.67%-1.84M
22.78%-3.08M
-Change in other current assets
-12.96%571K
-103.57%-2K
-73.90%65K
67.44%504K
-92.00%4K
209.15%656K
-1.75%56K
266.18%249K
133.86%301K
-69.33%50K
-Change in other current liabilities
35.02%-2.68M
36.02%-595K
34.01%-683K
35.98%-701K
34.12%-697K
0.10%-4.12M
12.84%-930K
2.36%-1.04M
-7.78%-1.1M
-8.07%-1.06M
Cash from discontinued investing activities
Operating cash flow
24.57%-68.26M
24.19%-13.94M
21.36%-15.6M
33.89%-15.61M
19.36%-23.11M
11.34%-90.5M
16.13%-18.39M
16.08%-19.84M
9.93%-23.62M
5.38%-28.66M
Investing cash flow
Cash flow from continuing investing activities
4,858.71%56.08M
-100.48%-67K
129.44%8.86M
15.60%24.99M
596.81%22.3M
-97.68%1.13M
194.53%14.1M
-198.72%-30.1M
-13.83%21.62M
-155.69%-4.49M
Net PPE purchase and sale
39.71%-618K
67.16%-67K
85.87%-26K
-94.52%-142K
32.09%-383K
17.27%-1.03M
48.22%-204K
-2,200.00%-184K
64.90%-73K
10.33%-564K
Net investment purchase and sale
2,550.82%56.7M
--0
129.69%8.89M
15.89%25.13M
677.81%22.69M
-95.72%2.14M
198.62%14.31M
-198.12%-29.93M
-14.24%21.68M
-145.12%-3.93M
Net other investing changes
----
----
----
----
----
168.00%17K
--0
400.00%12K
-55.56%4K
108.33%1K
Cash from discontinued investing activities
Investing cash flow
4,858.71%56.08M
-100.48%-67K
129.44%8.86M
15.60%24.99M
596.81%22.3M
-97.68%1.13M
194.53%14.1M
-198.72%-30.1M
-13.83%21.62M
-155.69%-4.49M
Financing cash flow
Cash flow from continuing financing activities
127.03%108.41M
15,348.81%58.24M
1,125.81%380K
-183.51%-476K
7.46%50.26M
1,079.28%47.75M
1.62%377K
31K
-86.36%570K
9,435.53%46.77M
Net common stock issuance
126.63%105.98M
--56.26M
--0
---546K
7.48%50.26M
1,108.95%46.76M
--0
--0
--0
--46.76M
Proceeds from stock option exercised by employees
146.00%2.43M
424.67%1.98M
1,125.81%380K
-87.72%70K
--0
44.72%987K
1.62%377K
--31K
83.28%570K
--9K
Cash from discontinued financing activities
Financing cash flow
127.03%108.41M
15,348.81%58.24M
1,125.81%380K
-183.51%-476K
7.46%50.26M
1,079.28%47.75M
1.62%377K
--31K
-86.36%570K
9,435.53%46.77M
Net cash flow
Beginning cash position
-89.77%4.74M
555.85%56.73M
7.75%63.09M
-9.66%54.19M
-89.77%4.74M
-51.54%46.36M
-89.56%8.65M
-22.94%58.55M
-17.76%59.99M
-51.54%46.36M
Current changes in cash
331.19%96.22M
1,231.91%44.24M
87.26%-6.36M
721.44%8.9M
263.01%49.45M
15.59%-41.62M
89.28%-3.91M
-828.51%-49.9M
-147.04%-1.43M
159.93%13.62M
End cash Position
2,029.19%100.97M
2,029.19%100.97M
555.85%56.73M
7.75%63.09M
-9.66%54.19M
-89.77%4.74M
-89.77%4.74M
-89.56%8.65M
-22.94%58.55M
-17.76%59.99M
Free cash flow
24.74%-68.88M
24.66%-14.01M
21.95%-15.63M
33.50%-15.76M
19.60%-23.5M
11.41%-91.53M
16.70%-18.59M
15.33%-20.02M
10.36%-23.69M
5.48%-29.22M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 24.57%-68.26M24.19%-13.94M21.36%-15.6M33.89%-15.61M19.36%-23.11M11.34%-90.5M16.13%-18.39M16.08%-19.84M9.93%-23.62M5.38%-28.66M
Net income from continuing operations 18.48%-90.6M15.36%-20.18M20.91%-20.28M20.89%-23.28M16.64%-26.86M10.44%-111.13M20.37%-23.84M12.04%-25.63M11.54%-29.43M-1.55%-32.23M
Depreciation and amortization -0.38%8.44M-12.54%1.83M-11.28%1.86M-1.84%2.08M23.48%2.66M-2.52%8.47M-4.22%2.09M-3.67%2.1M-3.28%2.12M1.17%2.16M
Other non cash items -23.26%2.9M-12.10%770K-38.52%688K-23.15%674K-15.30%764K12.69%3.77M1.15%876K31.96%1.12M5.79%877K11.91%902K
Change In working capital 69.03%-2.46M186.20%893K30.07%-921K151.93%1.01M5.61%-3.44M-40.42%-7.93M-54.40%-1.04M-7.60%-1.32M-383.89%-1.94M17.97%-3.64M
-Change in prepaid assets -36.17%547K1.18%-167K-591.07%-774K181.91%1.95M-202.91%-460K748.51%857K91.16%-169K-108.75%-112K88.28%691K22.13%447K
-Change in payables and accrued expense 83.14%-898K23,571.43%1.66M212.41%471K59.48%-744K25.86%-2.28M-419.10%-5.33M-99.69%7K72.29%-419K-182.67%-1.84M22.78%-3.08M
-Change in other current assets -12.96%571K-103.57%-2K-73.90%65K67.44%504K-92.00%4K209.15%656K-1.75%56K266.18%249K133.86%301K-69.33%50K
-Change in other current liabilities 35.02%-2.68M36.02%-595K34.01%-683K35.98%-701K34.12%-697K0.10%-4.12M12.84%-930K2.36%-1.04M-7.78%-1.1M-8.07%-1.06M
Cash from discontinued investing activities
Operating cash flow 24.57%-68.26M24.19%-13.94M21.36%-15.6M33.89%-15.61M19.36%-23.11M11.34%-90.5M16.13%-18.39M16.08%-19.84M9.93%-23.62M5.38%-28.66M
Investing cash flow
Cash flow from continuing investing activities 4,858.71%56.08M-100.48%-67K129.44%8.86M15.60%24.99M596.81%22.3M-97.68%1.13M194.53%14.1M-198.72%-30.1M-13.83%21.62M-155.69%-4.49M
Net PPE purchase and sale 39.71%-618K67.16%-67K85.87%-26K-94.52%-142K32.09%-383K17.27%-1.03M48.22%-204K-2,200.00%-184K64.90%-73K10.33%-564K
Net investment purchase and sale 2,550.82%56.7M--0129.69%8.89M15.89%25.13M677.81%22.69M-95.72%2.14M198.62%14.31M-198.12%-29.93M-14.24%21.68M-145.12%-3.93M
Net other investing changes --------------------168.00%17K--0400.00%12K-55.56%4K108.33%1K
Cash from discontinued investing activities
Investing cash flow 4,858.71%56.08M-100.48%-67K129.44%8.86M15.60%24.99M596.81%22.3M-97.68%1.13M194.53%14.1M-198.72%-30.1M-13.83%21.62M-155.69%-4.49M
Financing cash flow
Cash flow from continuing financing activities 127.03%108.41M15,348.81%58.24M1,125.81%380K-183.51%-476K7.46%50.26M1,079.28%47.75M1.62%377K31K-86.36%570K9,435.53%46.77M
Net common stock issuance 126.63%105.98M--56.26M--0---546K7.48%50.26M1,108.95%46.76M--0--0--0--46.76M
Proceeds from stock option exercised by employees 146.00%2.43M424.67%1.98M1,125.81%380K-87.72%70K--044.72%987K1.62%377K--31K83.28%570K--9K
Cash from discontinued financing activities
Financing cash flow 127.03%108.41M15,348.81%58.24M1,125.81%380K-183.51%-476K7.46%50.26M1,079.28%47.75M1.62%377K--31K-86.36%570K9,435.53%46.77M
Net cash flow
Beginning cash position -89.77%4.74M555.85%56.73M7.75%63.09M-9.66%54.19M-89.77%4.74M-51.54%46.36M-89.56%8.65M-22.94%58.55M-17.76%59.99M-51.54%46.36M
Current changes in cash 331.19%96.22M1,231.91%44.24M87.26%-6.36M721.44%8.9M263.01%49.45M15.59%-41.62M89.28%-3.91M-828.51%-49.9M-147.04%-1.43M159.93%13.62M
End cash Position 2,029.19%100.97M2,029.19%100.97M555.85%56.73M7.75%63.09M-9.66%54.19M-89.77%4.74M-89.77%4.74M-89.56%8.65M-22.94%58.55M-17.76%59.99M
Free cash flow 24.74%-68.88M24.66%-14.01M21.95%-15.63M33.50%-15.76M19.60%-23.5M11.41%-91.53M16.70%-18.59M15.33%-20.02M10.36%-23.69M5.48%-29.22M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Lebanese media reports, in the early hours of the 27th local time, Iran conveyed a three-phase negotiation plan to the US throu Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -